angiotensin ii has been researched along with tranilast in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuyama, J; Hamano, S; Misawa, K; Miyazawa, K; Ujiie, A | 1 |
| Jin, D; Miyazaki, M; Shiota, N; Takai, S | 1 |
| Chen, WQ; Guo, T; Zhang, C; Zhang, Y; Zhao, YX | 1 |
| Bai, N; Li, G; Li, J; Li, L; Li, T; Li, W; Liu, G; Lou, Q; Wang, Y; Yang, W; Zhan, C; Zhang, L; Zhao, H; Zheng, M | 1 |
| Chen, Y; He, D; Huang, M; Yan, Y | 1 |
5 other study(ies) available for angiotensin ii and tranilast
| Article | Year |
|---|---|
Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anticoagulants; Antihypertensive Agents; Aorta, Thoracic; Becaplermin; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Humans; Imidazoles; Inositol Phosphates; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; ortho-Aminobenzoates; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rabbits; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1996 |
Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Aorta; Arteries; Cromolyn Sodium; Dose-Response Relationship, Drug; Histamine Antagonists; Humans; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; ortho-Aminobenzoates; Potassium Chloride; Pyridines; Pyrimidinones; Rabbits; Vasoconstriction | 1998 |
Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Atherosclerosis; Body Weight; Cell Degranulation; Cholesterol; Chymases; Cricetinae; Disease Models, Animal; Disease Progression; Immunohistochemistry; Inflammation; Inflammation Mediators; Lipids; Male; Mast Cells; Mesocricetus; Microscopy, Electron, Transmission; ortho-Aminobenzoates; Ovalbumin; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rupture; Time Factors; Ultrasonography, Doppler, Duplex | 2009 |
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Doxorubicin; Fibrosis; Heart Diseases; Male; Mast Cells; Myocardium; ortho-Aminobenzoates; Oxidative Stress; Rats; Rats, Wistar | 2021 |
Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis.
Topics: Angiotensin II; Cardiomyopathies; Cell Movement; Cell Survival; Cells, Cultured; Fibrosis; Humans; ortho-Aminobenzoates; S100 Proteins; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2021 |